![Inceptor Bio](https://storage.googleapis.com/dealroom-images-production/e7/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA2LzE5LzI5NmMzNWRjMWJjZjU1Y2JjNDE5MjIzYmQzZTk3ZWFh.png)
Inceptor Bio
VerifiedDeveloping multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$189m (Public information from Nov 2022)
Raleigh North Carolina (HQ)
Authorizing premium user...